Related Experiment Video
Updated: Jan 26, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
3-Substituted Quinolines as RORγt Inverse Agonists.
Virginia M Tanis1, Hariharan Venkatesan1, Maxwell D Cummings2
1Discovery Product Development and Supply, Janssen Research and Development, 3210 Merryfield Row, San Diego, CA 92121, United States.
Researchers improved drug properties by modifying quinoline compounds targeting retinoic acid receptor-related orphan receptor gamma t (RORγt). New molecules show potent binding and better solubility, addressing previous limitations.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Previous work synthesized 3,6-disubstituted quinolines as modulators of retinoic acid receptor-related orphan receptor gamma t (RORγt).
- These compounds demonstrated potent binding but suffered from high molecular weight and poor solubility at pH 2 and pH 7.
Purpose of the Study:
- To enhance the physical-chemical properties of the 3,6-disubstituted quinoline series.
- To improve solubility and reduce molecular weight while maintaining potent RORγt binding.
Main Methods:
- Systematic modification of the 3-position of the quinoline core.
- Introduction of diverse heteroatoms at the 3-position.
- Evaluation of molecular weight and solubility at physiological and acidic pH.
Main Results:
- Successful diversification at the 3-position led to reduced molecular weight.
- The modified compounds exhibited significantly improved solubility profiles.
- Potent binding to retinoic acid receptor-related orphan receptor gamma t (RORγt) was retained.
Conclusions:
- Chemical modification strategies successfully addressed the poor solubility and high molecular weight issues.
- The optimized quinoline derivatives represent promising drug candidates with improved drug-like properties for RORγt modulation.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Inverse Hyperbolic Functions and Their Derivatives
Derivatives of Inverse Trigonometric Functions
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

